| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |